This blood-based test provides a non-invasive biochemical approach to complement
traditional methods that have been used to check for pancreatic cancer
The Benefits of a Blood-based Test
3 Reasons Why Pancreatic Cancer
has been hard to detect
- 1. People don’t usually experience any clear symptoms until the cancer has spread throughout the pancreas or into neighboring organs
- 2. When symptoms do arise they can go unnoticed and can be hard to diagnose. Back or stomach pain, weight loss, nausea and vomiting, or unusual color to stool or urine can all be symptoms of pancreatic cancer.
- 3. Imaging tests like CT Scans and MRIs are expensive, hard to schedule, and can sometimes produce inconclusive results
The Science Behind the Test
- – DNA Methylation is a process by which DNA molecules are turned off and on to regulate cellular functions
- – The test can detect abnormal DNA Methylation signatures in your blood that can be a tell-tale sign that pancreatic cancer is present
- – On a molecular level, the test examines 59 distinct DNA Methylation regions (or biomarkers) that have all been specifically linked to pancreatic cancer